Live from the NIH registry
Studies recruiting near Hickory right now
Top 25 of 94 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Phase 3
Interventional 2,500 participants sought
Research Site — Statesville, North Carolina (24.6 mi)
· Sponsor: AstraZeneca
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Atrium Health Lincoln/LCI-Lincolnton — Lincolnton, North Carolina (18.9 mi)
· Sponsor: NRG Oncology
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8
Phase 1, Phase 2
Interventional 92 participants sought
Wake Forest Baptist Health - Wilkes Medical Center — Wilkesboro, North Carolina (29.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy, Macular Degeneration
Phase 2, Phase 3
Interventional 274 participants sought
Graystone Eye — Hickory, North Carolina (1.2 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Major Depressive Disorder
Phase 4
Interventional 350 participants sought
Clinical Research Site — Hickory, North Carolina (1.2 mi)
· Sponsor: Axsome Therapeutics, Inc.
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
OnSite Clinical Solutions - Ninth Ave Drive North East - Hickory /ID# 227994 — Hickory, North Carolina (1.2 mi)
· Sponsor: AbbVie
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Wake Forest Baptist Health - Wilkes Medical Center — Wilkesboro, North Carolina (29.4 mi)
· Sponsor: NRG Oncology
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Statesville, North Carolina (24.6 mi)
· Sponsor: AstraZeneca
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Atrium Health Lincoln/LCI-Lincolnton — Lincolnton, North Carolina (18.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Graystone Eye — Hickory, North Carolina (1.2 mi)
· Sponsor: EyeBiotech Ltd.
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
Phase 3
Interventional 54,000 participants sought
GSK Investigational Site — Hickory, North Carolina (1.2 mi)
· Sponsor: GlaxoSmithKline
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Statesville, North Carolina (24.6 mi)
· Sponsor: Akero Therapeutics, Inc
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
Hypercholesterolaemia
Phase 3
Interventional 600 participants sought
Research Site — Statesville, North Carolina (24.6 mi)
· Sponsor: AstraZeneca
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Wake Forest Baptist Health - Hematology Oncology - Statesville — Statesville, North Carolina (24.6 mi)
· Sponsor: National Cancer Institute (NCI)
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Breast Cancer, NOS, CNS Primary Tumor, NOS
N/A
Interventional 400 participants sought
CaroMont Health - Lincoln Cancer Center — Lincolnton, North Carolina (18.9 mi)
· Sponsor: Eastern Cooperative Oncology Group
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Obesity or Overweight, Weight-Related Comorbidity
Phase 3
Interventional 500 participants sought
Research Site — Statesville, North Carolina (24.6 mi)
· Sponsor: AstraZeneca
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Phase 3
Interventional 6,950 participants sought
Research Site — Statesville, North Carolina (24.6 mi)
· Sponsor: AstraZeneca
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
Schizophrenia
Phase 3
Interventional 280 participants sought
Local Institution - 176 — Hickory, North Carolina (1.2 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
EDS, Cataplexy
Phase 3
Interventional 258 participants sought
Research Carolina Elite LLC — Denver, North Carolina (21.9 mi)
· Sponsor: Harmony Biosciences Management, Inc.
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2
Interventional 90 participants sought
Denver, North Carolina — Denver, North Carolina (21.9 mi)
· Sponsor: Centessa Pharmaceuticals (UK) Limited
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Piedmont Healthcare - Family Medicine- Site Number : 8400022 — Statesville, North Carolina (24.6 mi)
· Sponsor: Sanofi
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Obesity, Overweight
Phase 3
Interventional 3,200 participants sought
Accellacare of Hickory — Hickory, North Carolina (1.2 mi)
· Sponsor: Amgen
Family Communications After Genetic Testing
Colon Adenocarcinoma, Colorectal Adenocarcinoma
N/A
Interventional 4,186 participants sought
CaroMont Health - Lincoln Cancer Center — Lincolnton, North Carolina (18.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Colorectal Cancer, Sarcopenia
N/A
Observational 300 participants sought
Wake Forest Baptist Health - Wilkes Medical Center — Wilkesboro, North Carolina (29.4 mi)
· Sponsor: Wake Forest University Health Sciences
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
IMA Research — Lenoir, North Carolina (17.0 mi)
· Sponsor: Novo Nordisk A/S